110802-16-9

Basic information

• Product Name: 7-CHLORO-2-PHENYL-4-QUINOLINOL
• Synonyms: 7-Chloro-4-hydroxy-2-phenylquinoline;7-CHLORO-2-PHENYL-4-QUINOLINOL
• CAS NO: 110802-16-9
• Molecular Formula: C₁₅H₁₀ClNO
• Molecular Weight: 255.7
• Mol File: 110802-16-9.mol

Chemical Properties

• Boiling Point: 418.5°C at 760 mmHg
• Flash Point: 206.9°C
• Appearance: /
• Density: 1.303g/cm³
• Vapor Pressure: 3.26E-07mmHg at 25°C
• Refractive Index: 1.641
• CAS DataBase Reference: 7-CHLORO-2-PHENYL-4-QUINOLINOL(CAS DataBase Reference)
• NIST Chemistry Reference: 7-CHLORO-2-PHENYL-4-QUINOLINOL(110802-16-9)
• EPA Substance Registry System: 7-CHLORO-2-PHENYL-4-QUINOLINOL(110802-16-9)

Safety Data

• Hazardous Substances Data: 110802-16-9(Hazardous Substances Data)

Usage

InChI:InChI=1/C15H10ClNO/c16-11-6-7-12-14(8-11)17-13(9-15(12)18)10-4-2-1-3-5-10/h1-9H,(H,17,18)

Upstream product

• 6004-21-3 3'-chloro-benzanilide 
• 5900-58-3 2-amino-4-chloro-benzoic acid methyl ester 
• 4316-35-2 acetophenone dimethyl acetal 
• 89-77-0 2-Amino-4-chlorobenzoic acid 
• 108-42-9 3-chloro-aniline 
• 93663-75-3 7-chloro-4-hydroxy-2-phenyl-quinoline-3-carboxylic acid ethyl ester 
• 1611-02-5 2-cyano-3-oxo-3-phenyl-propionic acid ethyl ester 
• 34918-77-9 N-(3-chlorophenyl)benzimidoyl chloride 
• 94-02-0 ethyl 3-oxo-3-phenylpropionate 
• 500301-58-6 7-chloro-4-hydroxy-2-phenyl-quinoline-3-carboxylic acid 
• 4316-37-4 1,1,-diethoxy-1-phenylethane 
• 60064-34-8 2-Carboethoxy-5-chloroaniline 

Downstream Products

• 1304632-35-6 7-chloro-2-phenyl-(quinoline-4-d) 
• 1189106-03-3 4-bromo-7-chloro-2-phenylquinoline 
• 1440084-90-1 7-chloro-4-methoxy-2-phenylquinoline 
• 1440084-95-6 7-chloro-4-ethoxy-2-phenylquinoline 
• 1440084-86-5 4-ethoxy-2-phenyl-7-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)quinoline 
• 1440084-83-2 4-methoxy-2-phenyl-7-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)quinoline 

Relevant articles and documents

QUINOLINES DERIVATIVES AS NOVEL ANTICANCER AGENTS

The invention provides quinoline derivatives, their manufacture, pharmaceutical compositions containing them, and their use as medicaments. The active compounds of the present invention are useful for the treatment of proliferative neoplastic and nonneoplastic diseases.

Discovery of novel insulin-like growth factor-1 receptor inhibitors with unique time-dependent binding kinetics

This letter describes a series of small molecule inhibitors of IGF-1R with unique time-dependent binding kinetics and slow off-rates. Structure-activity and structure-kinetic relationships were elucidated and guided further optimizations within the series

DEUTERATED TYROSINE KINASE INHIBITORS

Compounds of Formula I, as shown below and defined herein: enriched in deuterium, and pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers mediated at least in par

Amides derived from quinoline, and anxiolytic compositions containing them

Compounds of formula: STR1 in which V and W are H, halogen, alkyl (1-4C) or alkoxy (1-4C), amino, or acylamino,Z is phenyl, optionally substituted, thienyl, or pyridyl,R 1 is alkyl (1-6C), alkoxyalkyl, cycloalkyl (3-6C), phenyl, phenylalkyl, or cycloalkyl